AskBio

Acquired

AAV Gene Therapy Technology & Therapeutics

Research Triangle Park, United States · Founded 2011 · $225.0M raised

Employees
201–500
Founded
2011
Business Model
B2B
Website
askbio.com
Total Funding
$225.0M
Last Round
$225.0M Growth EquityJan 2019
Rounds
1
Acquisition Date
Oct 2020

About

AskBio (Asklepios BioPharmaceutical) is a fully integrated gene therapy company and wholly owned subsidiary of Bayer AG, specializing in AAV-based therapies for genetic and neurological disorders. Its pipeline includes investigational treatments for Parkinson's disease, Pompe disease, and heart failure. AskBio's proprietary Pro10 manufacturing platform and neDNA technology support clinical-stage and commercial-scale gene therapy production.

Summary

AskBio is a Biotech company based in Research Triangle Park, United States, founded in 2011. It has raised $225.0M in total across 1 round, most recently a $225.0M Growth Equity round in Jan 2019. Investors include Leaps by Bayer, TPG (Growth/Rise) and Vida Ventures.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

AcquisitionOct 2020

Sign up to see all 2 events

Funding: Growth Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

AskBio on Indexed.vc
<a href="https://indexed.vc/companies/askbio"><img src="https://indexed.vc/api/badge/company/askbio" alt="AskBio on Indexed.vc" width="260" height="76" /></a>